Reading time is 7 mins
.
.
SILENT PANDEMIC: CHRONIC KIDNEY DISEASE
The Turkish Society of Nephrology, an institution that has proven its reputation worldwide through its scientific work at the national and international levels, revealed the striking effects of chronic kidney disease, also known as a ‘silent epidemic’, at a press conference held as part of the “World Kidney Day” events of 2021.
Chronic kidney disease attracts attention as an important public health problem that has become an epidemic in the world and in our country. If kidney disease is detected early, it can often be prevented or delayed. But low awareness of the disease does not allow it to be detected at an early stage. Due to the fact that individuals are not aware of their disease, “end-stage kidney failure” develops and the quality of life deteriorates.
He noted that the disease is progressing at the global threat level and has very serious consequences, Professor, president of the Turkish Society of Nephrology Dr. “Chronic kidney disease affects one in 10 adults in the world, and every year 2.5 million people die due to problems caused by the disease, and unfortunately Turkey is among the countries with the highest incidence of kidney disease,” said.
.
I’M KIDNEY SICK, ADDICTED TO LIFE ‘ CAMPAIGN
In order to improve the quality of life of people with kidney disease, to support their connection and participation in all aspects of life, the global motto of World Kidney Day this year was determined as “living well with kidney disease”.
- Every year since 2006, increasing community awareness about kidney health and disease World Kidney Day special, emphasize the importance of early diagnosis of kidney disease and a heavy burden on human health to inform the public about who is working in Turkish nephrology Association 2021 World Kidney Day during the week and “I’m a kidney patient, I am bound for life with the slogan” is organizing awareness-raising activities.
.
- President Of The Turkish Society Of Nephrology Prof. Dr. “to evaluate the quality of life of our patients and to conduct studies on the problems identified afterwards, we have prepared a quality of life questionnaire. According to the results of this survey, only a third (34 percent) of patients said that their quality of life was good. According to this survey, 3 out of every 4 kidney patients stated that their illness affected their daily physical activity, work status (at work or at home), sleep patterns, and the enjoyment they received from life. Two-thirds of patients said their illness affected their responsibilities to their families, their capacity to travel and their sex life. The vast majority of patients (87 percent) said they were satisfied with the family support they received, and similarly, 91 percent said they were satisfied with the health care they received. Renal patients, 82% of the diet from doing, from using drugs or 85 percent, 84 percent, the hospital often have to go out of control, 81% of doctors or other health care providers from being dependent on 88 percent uncertainty for the future and 78% have stated that they were uncomfortable albeit to varying degrees, from being a burden to their families.
.
2.5 MILLION PEOPLE LOSE THEIR LIVES EVERY YEAR
- About 2.5 million people die each year due to the problems caused by the disease, said Prof. Dr. said, ” the rates of disability and death in chronic kidney patients due to accompanying problems, especially cardiovascular diseases, are quite high. And these patients may need to be hospitalized frequently. Moreover, although there is a decrease in mortality in many diseases such as cardiovascular diseases, cancer, COPD, chronic kidney disease is increasing. Currently, chronic kidney disease is responsible for 4.5 percent of all deaths. As a result, chronic kidney disease ranked 17th among all causes of death in 1990. while in line, he is currently 12th. 5 in 2040. it is expected that he will rise to the line,” he said.
.
COVID-19 RISK IN KIDNEY PATIENTS
World Kidney Day, which coincides with March 11, 2021 this year, is also the first anniversary of the day when the first case of Covid-19 was announced in Turkey, the Secretary General of the Association professor stressed Dr. noted:
- “This epidemic, which has affected the whole world, has also caused significant problems in our country and has unfortunately caused many of our people and health workers to lose their lives. The Turkish Society of Nephrology evaluated the data of more than a thousand kidney patients who were hospitalized in the first months of the outbreak and shared it with the international scientific world. Data conducted under the title” Turkish Society of Nephrology Covid-19 Experience Sharing ” and collected with the participation of 71 nephrologists in 47 nephrology clinics in Turkey showed that the mortality rate in chronic kidney patients receiving hospitalization due to Covid-19 was 28.4 percent, 16.2 percent in hemodialysis patients and 11.1 percent in kidney transplant patients.”
.
THEY NEED TO TAKE STRICTER MEASURES
Kidney patients represent one of the highest risk groups in terms of Covid-19 and affect the usual care processes of these patients, said Prof. Dr. continued:
- “People with chronic kidney disease before the pandemic constitute the most severe risk group of Covid-19 disease. The immune system of kidney patients undergoing dialysis treatment is not strong enough to fight infections. Therefore, these people may have a predisposition to infectious diseases due to weakened body defenses. Dialysis patients should continue their planned dialysis treatment without decess, taking the necessary precautions to be taken by health workers and authorities. In the same way, although people who have undergone kidney transplants have been somewhat vulnerable to infectious diseases due to the immunosuppressive drugs they use to avoid organ rejection, it is vital that they continue to use their medications. It is recommended that these people be more careful during the pandemic period, take stricter measures, do not disrupt their treatment and stay in their homes as much as possible, except for treatment requirements.”
.
- Covid-19 questions asked in the quality of life survey also revealed interesting results. 92 percent of kidney patients said they were concerned about the Covid-19 outbreak to varying degrees. Almost half (47 percent) of patients experienced problems associated with their kidney health and treatment during the Covid-19 outbreak. Of almost every 4 patients who completed the survey, 3 (73 percent) had not yet received the Covid-19 vaccine. 76 percent of patients are also concerned about the effects and side effects of the vaccine.
.
GLOBAL COST OF DIALYSIS AND KIDNEY TRANSPLANTATION: $ 1.5 TRILLION
- Noting that the chronic kidney disease poses a global threat to the health economy, Turkey Medicals to AA correspondent in a statement said: “chronic kidney disease is often a progressive disease. Loss of more than 85-90 percent of the filtering function of the kidneys is called End-stage kidney disease. In order for patients who have reached the last period to survive, dialysis or kidney transplant treatments must be applied. There are currently around 3.5 million dialysis or kidney transplant patients worldwide. This number is expected to reach 5.5 million by 2030.
.
- In our country, the number of patients undergoing dialysis or kidney transplantation has increased 2.5 times in the last 15 years and is now close to 85,000. Dialysis and kidney transplantation are expensive treatments and seriously threaten countries ‘ health budgets. Although there are differences between countries, about 5 percent of health budgets are spent on these treatments. The global cost of dialysis and kidney transplantation is estimated to be around $ 1.5 trillion. With the inclusion of follow-up and treatment costs of early stage patients, the burden of the disease on the health economy increases much more,” was said.
.
THE MOST IMPORTANT CAUSE IS DIABETES
- Diabetes and hypertension are cited as the most important causes that lead to chronic kidney disease in the world and in Turkey.
.
- Worldwide, the incidence of diabetes, which was 4 percent in 1995, has reached 10 percent today. At this rate of increase, the number of patients, which is still around 465 million, is expected to reach 700 million in the next 20-25 years.
.
- In our country, the frequency of diabetes is also increasing dramatically. The frequency, which was 5.2 percent in 1995, rose to 13.7 percent in 2010, although only 15 years have passed. Currently, this figure is estimated to exceed 15 percent.
.
- 30-40 percent of people with diabetes develop kidney disease. In the CREDIT study, chronic kidney disease was detected in 32.4 percent of people with diabetes in Turkey. This rate is 2.5 times higher than those who are not diabetic. According to data from Turkish Society of Nephrology’s kidney registration system, diabetes is the main cause in about 40 percent of patients who have just started dialysis.
.
ONE IN EVERY 6-7 ADULTS IN TURKEY HAS KIDNEY DISEASE
- Chronic kidney disease is considered one of the most important public health problems seen in one in 10 adults worldwide, while there are about 850 million kidney patients worldwide. This number is higher than the number of patients with diabetes, cardiovascular disease, cancer, COPD and depression, which are common diseases.
.
- A CREDIT study conducted by the Turkish Society of Nephrology shows that 15.7 percent of adults in our country have chronic kidney disease. According to this, one out of every 6-7 adults in our country has kidney disease and the disease still affects more than 9 million of our citizens.
.
EARLY DIAGNOSIS IS IMPORTANT
- Who are at risk of chronic kidney disease (diabetes, hypertension, cardiovascular disease, obesity or kidney disease, or advanced Age) individuals from the early stages of the disease needs to be monitored regularly and kidney function in renal protective the start of treatment is very important. Early detection is also important for your kidney health.
.
.
.
President of Organ Transplant Center at MedicalPark Hospital Antalya
Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.
Physician's Resume:
Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.
Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.
In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.
Awards:
Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.
Certificates:
Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .
Professional Members:
American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.
Disclaimer:
Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.
Physician's Resume:
Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.
Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.
In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.
Awards:
Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.
Certificates:
Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .
Professional Members:
American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.
Disclaimer:
Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Latest posts by Medically Reviewed by Professor Doctor Alper Demirbaş (see all)
- CRANIOCERVICAL SYNDROME MISALIGNMENT IN THE UPPER CERVICAL REGION - 16/04/2024
- MISALIGNMENT OF THE UPPER CERVICAL BONES (C1-C2) - 16/04/2024
- WHAT IS GLOSSOPHARYNGEAL NEURALGIA (SORE THROAT)? - 16/04/2024